Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Kowa submits NDA to FDA for pitavastatin

Oct. 28, 2008

FDA approves LoSeasonique oral contraceptive

Oct. 28, 2008

Recent patent literature discloses novel therapeutic agents for metabolic disorders

Oct. 28, 2008

Phenomix and Forest sign development and commercialization agreement for dutogliptin

Oct. 27, 2008

Recent Biovitrum and Merck patents describe new therapeutic agents for obesity

Oct. 27, 2008

Columbia signs collaboration agreement with NIH for phase III PREGNANT study of Prochieve

Oct. 27, 2008

Oxygen to conduct safety and efficacy clinical trial of Oxycyte in TBI

Oct. 27, 2008

Oramed launches phase Ia insulin suppository trial

Oct. 27, 2008

EMEA recommends temporary suspension of Acomplia marketing authorization in obese patients

Oct. 24, 2008

Recent Tufts College and TransTech patents disclose novel antidiabetic agents

Oct. 24, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...